The State of Texas Top Legal Officer Takes Legal Action Against Tylenol Manufacturers Regarding Autism Assertions
The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, claiming the companies concealed potential risks that the pain reliever presented to pediatric neurological development.
The court filing follows thirty days after President Donald Trump promoted an unsubstantiated connection between consuming Tylenol - alternatively called acetaminophen - during pregnancy and autism in young ones.
The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which currently produces it.
In a official comment, he stated they "betrayed America by gaining financially from suffering and pushing pills ignoring the risks."
The company asserts there is no credible evidence connecting Tylenol to autism spectrum disorder.
"These companies misled for generations, knowingly endangering millions to increase profits," Paxton, a Republican, said.
The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the health of American women and children."
On its website, the company also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a verified association between using paracetamol and autism spectrum disorder."
Groups speaking for medical professionals and health professionals share this view.
The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in acetaminophen - is a restricted selection for pregnant women to treat pain and elevated temperature, which can create serious health risks if ignored.
"In over twenty years of research on the consumption of paracetamol in pregnancy, zero credible investigations has definitively established that the consumption of paracetamol in any trimester of gestation causes brain development issues in offspring," the group said.
This legal action mentions recent announcements from the previous government in arguing the drug is reportedly hazardous.
Last month, Trump raised alarms from medical authorities when he told pregnant women to "resist strongly" not to use acetaminophen when sick.
Federal regulators then published an announcement that medical professionals should contemplate reducing the usage of acetaminophen, while also stating that "a proven link" between the medication and autism in young ones has remains unverified.
The Health Department head RFK Jr, who supervises the FDA, had pledged in April to conduct "extensive scientific investigation" that would identify the origin of autism in a short period.
But experts cautioned that finding a unique factor of autism - thought by researchers to be the outcome of a complex mix of genetic and external influences - would not be simple.
Autism spectrum disorder is a form of enduring cognitive variation and condition that affects how persons perceive and engage with the world, and is identified using doctors' observations.
In his court filing, the attorney general - aligned with the former president who is running for US Senate - asserts the manufacturer and J&J "intentionally overlooked and tried to quiet the research" around paracetamol and autism spectrum disorder.
The case attempts to require the firms "destroy any marketing or advertising" that claims acetaminophen is safe for women during pregnancy.
The Texas lawsuit parallels the complaints of a assembly of guardians of children with autism spectrum disorder and ADHD who took legal action against the producers of Tylenol in recently.
Judicial authorities threw out the case, stating studies from the family's specialists was not conclusive.